Organ-preserving treatment using neoadjuvant chemotherapy during intravesical immunotherapy with roncoleukin (interleukin-2) for invasive bladder carcinoma
The results of a prospective randomized study of the efficacy of neoadjuvant chemoimmunotherapy with intravesical roncoleukin (interleukin- 2) versus the standard M-VAC chemotherapy regimen are analyzed. The study protocol included 60 patients. Additional intravesical administration of roncoleukin f...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2020-03-01
|
| Series: | Onkourologiâ |
| Online Access: | https://oncourology.abvpress.ru/oncur/article/view/1258 |